RAHIL SHAH: Open Payments
NPI 1194495085 · DENISON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 14 payments from 10 companies in 2025. Trend: 2023 $639 · 2024 $3,036 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Adaptive Biotechnologies Corporation | 1 | $123 |
| ABBVIE INC. | 3 | $50 |
| Janssen Biotech, Inc. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Geron Corporation | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Nuvation Bio Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| PFIZER INC. | 1 | $14 |
Products named: clonoSEQ, KISQALI, VENCLEXTA, RYTELO, BLENREP, IBTROZI, TECVAYLI, TALVEY.
Industry payments across TX — which companies pay providers there.
